BRPI0818559A2 - Compostos orgânicos - Google Patents

Compostos orgânicos

Info

Publication number: BRPI0818559A2
Authority: BR; Brazil
Prior art keywords: organic compounds; compounds; organic
Prior art date: 2007-10-12

Application number

Other languages

English (en)

Inventor

Patrick Chene

Carlos Garcia-Echeverria

Michael Rugaard Jensen

Cornelia Quadt

Thomas Radimerski

Joseph Schoepfer

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-12

Filing date

2008-10-10

Publication date

2015-04-22

2008-10-10 Application filed by Novartis Ag filed Critical Novartis Ag

2015-04-22 Publication of BRPI0818559A2 publication Critical patent/BRPI0818559A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
Obesity (AREA)
Dermatology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

BRPI0818559 2007-10-12 2008-10-10 Compostos orgânicos BRPI0818559A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07118421		2007-10-12
PCT/EP2008/063605 WO2009047323A2 (en)	2007-10-12	2008-10-10	Organic compounds

Publications (1)

Publication Number	Publication Date
BRPI0818559A2 true BRPI0818559A2 (pt)	2015-04-22

Family

ID=38952098

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818559 BRPI0818559A2 (pt)	2007-10-12	2008-10-10	Compostos orgânicos

Country Status (19)

Country	Link
US (6)	US20100210650A1 (pt)
EP (3)	EP2209529B1 (pt)
JP (2)	JP5800504B2 (pt)
KR (4)	KR20100075902A (pt)
CN (2)	CN101795728A (pt)
AU (1)	AU2008309562B2 (pt)
BR (1)	BRPI0818559A2 (pt)
CA (1)	CA2700795C (pt)
CL (1)	CL2008003005A1 (pt)
ES (1)	ES2500920T3 (pt)
MA (1)	MA31765B1 (pt)
MX (1)	MX2010003988A (pt)
PL (1)	PL2263751T3 (pt)
PT (1)	PT2263751E (pt)
RU (1)	RU2491938C2 (pt)
TN (1)	TN2010000139A1 (pt)
TW (1)	TW200922595A (pt)
WO (1)	WO2009047323A2 (pt)
ZA (1)	ZA201001546B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2017119219A (ru) *	2011-10-14	2018-11-02	Новартис Аг	2-карбоксамид циклоамино производные мочевины в комбинации с ингибиторами hsp90 для лечения пролиферативных заболеваний
BR112015021846A2 (pt) *	2013-03-15	2017-07-18	Novartis Ag	biomarcador
US10300026B2 (en) *	2015-08-24	2019-05-28	Shanxi Yabao Health Products Co., Ltd.	Use of dihydroxyacetone in preparation of anti-cancer medicaments
KR102653960B1 (ko) *	2020-07-23	2024-04-03	의료법인 성광의료재단	암 치료를 위한 면역체크포인트 억제제의 병용 요법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003282512A1 (en) *	2002-10-22	2004-05-13	The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services	Methods of reducing the activity of and reducing the concentration of a mutant kit protein
KR101166749B1 (ko)	2003-02-11	2012-07-27	베르날리스(캠브리지)리미티드	열쇼크 단백질 저해제로서의 이소옥사졸 화합물
US20050054625A1 (en) *	2003-05-30	2005-03-10	Kosan Biosciences, Inc.	Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
US20070027150A1 (en) *	2005-04-14	2007-02-01	Bellamacina Cornelia R	2-Amino-quinazolin-5-ones
US20070105862A1 (en) *	2005-11-10	2007-05-10	Milan Bruncko	Heat-shock protein binders
ES2384906T3 (es) *	2007-03-01	2012-07-13	Novartis Ag	Mesilato de etilamida del ácido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, hidratos y polimorfos del mismo y formulaciones que comprenden estas formas

2008
- 2008-10-09 TW TW097139091A patent/TW200922595A/zh unknown
- 2008-10-10 AU AU2008309562A patent/AU2008309562B2/en not_active Ceased
- 2008-10-10 PT PT101742765T patent/PT2263751E/pt unknown
- 2008-10-10 RU RU2010118458/15A patent/RU2491938C2/ru not_active IP Right Cessation
- 2008-10-10 JP JP2010528411A patent/JP5800504B2/ja not_active Expired - Fee Related
- 2008-10-10 KR KR1020107007726A patent/KR20100075902A/ko not_active Ceased
- 2008-10-10 CL CL2008003005A patent/CL2008003005A1/es unknown
- 2008-10-10 ES ES10174276.5T patent/ES2500920T3/es active Active
- 2008-10-10 KR KR1020177031591A patent/KR20170124642A/ko not_active Ceased
- 2008-10-10 US US12/680,657 patent/US20100210650A1/en not_active Abandoned
- 2008-10-10 CA CA2700795A patent/CA2700795C/en not_active Expired - Fee Related
- 2008-10-10 EP EP08836801.4A patent/EP2209529B1/en not_active Not-in-force
- 2008-10-10 EP EP10174276.5A patent/EP2263751B1/en not_active Not-in-force
- 2008-10-10 MX MX2010003988A patent/MX2010003988A/es active IP Right Grant
- 2008-10-10 WO PCT/EP2008/063605 patent/WO2009047323A2/en not_active Ceased
- 2008-10-10 EP EP18187344.9A patent/EP3427797A1/en not_active Withdrawn
- 2008-10-10 CN CN200880105578A patent/CN101795728A/zh active Pending
- 2008-10-10 KR KR1020167008429A patent/KR20160040738A/ko not_active Withdrawn
- 2008-10-10 BR BRPI0818559 patent/BRPI0818559A2/pt not_active Application Discontinuation
- 2008-10-10 CN CN201410455814.4A patent/CN104306377A/zh active Pending
- 2008-10-10 PL PL10174276T patent/PL2263751T3/pl unknown
- 2008-10-10 KR KR1020167033776A patent/KR101841872B1/ko not_active Expired - Fee Related
2010
- 2010-03-03 ZA ZA201001546A patent/ZA201001546B/xx unknown
- 2010-03-26 TN TNP2010000139A patent/TN2010000139A1/fr unknown
- 2010-04-08 MA MA32755A patent/MA31765B1/fr unknown
2011
- 2011-12-08 US US13/314,584 patent/US20120083496A1/en not_active Abandoned
2012
- 2012-05-02 US US13/461,855 patent/US20120214813A1/en not_active Abandoned
2014
- 2014-05-02 US US14/267,946 patent/US20140288075A1/en not_active Abandoned
- 2014-05-02 JP JP2014095330A patent/JP2014156475A/ja not_active Withdrawn
2015
- 2015-10-28 US US14/925,263 patent/US20160045513A1/en not_active Abandoned
2016
- 2016-04-12 US US15/096,397 patent/US20160220576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MX2010003988A (es)	2010-04-27
AU2008309562B2 (en)	2012-01-19
JP5800504B2 (ja)	2015-10-28
US20100210650A1 (en)	2010-08-19
US20160045513A1 (en)	2016-02-18
KR20100075902A (ko)	2010-07-05
WO2009047323A2 (en)	2009-04-16
CA2700795C (en)	2017-03-07
KR20170124642A (ko)	2017-11-10
EP2263751B1 (en)	2014-07-09
US20160220576A1 (en)	2016-08-04
EP2263751A1 (en)	2010-12-22
CN101795728A (zh)	2010-08-04
US20120083496A1 (en)	2012-04-05
CN104306377A (zh)	2015-01-28
JP2011500535A (ja)	2011-01-06
PL2263751T3 (pl)	2014-12-31
KR20160143877A (ko)	2016-12-14
ZA201001546B (en)	2010-10-27
EP2209529B1 (en)	2018-09-19
TN2010000139A1 (en)	2011-09-26
CL2008003005A1 (es)	2009-05-08
RU2491938C2 (ru)	2013-09-10
MA31765B1 (fr)	2010-10-01
US20120214813A1 (en)	2012-08-23
ES2500920T3 (es)	2014-10-01
EP2209529A2 (en)	2010-07-28
EP3427797A1 (en)	2019-01-16
RU2010118458A (ru)	2011-11-20
KR101841872B1 (ko)	2018-03-26
AU2008309562A1 (en)	2009-04-16
US20140288075A1 (en)	2014-09-25
KR20160040738A (ko)	2016-04-14
CA2700795A1 (en)	2009-04-16
JP2014156475A (ja)	2014-08-28
WO2009047323A3 (en)	2009-11-12
TW200922595A (en)	2009-06-01
PT2263751E (pt)	2014-09-10

Publication	Publication Date	Title
DK2240490T3 (da)	2013-12-16	Organiske forbindelser
BRPI0817434A2 (pt)	2015-06-16	Composto orgânicos
BRPI0811562A2 (pt)	2014-12-09	Compostos orgânicos
BRPI0922351A2 (pt)	2018-06-05	compostos orgânicos
BRPI0922700A2 (pt)	2015-08-11	Compostos orgânicos
BRPI0922808A2 (pt)	2018-05-29	compostos orgânicos
BRPI0922131A2 (pt)	2015-08-18	Compostos orgânicos
BRPI0922348A2 (pt)	2015-08-11	Compostos orgânicos
BRPI0922809A2 (pt)	2018-05-29	compostos orgânicos
BRPI0913966A2 (pt)	2015-11-17	compostos orgânicos
BRPI0914698A2 (pt)	2015-10-20	compostos orgânicos
BRPI0909417A2 (pt)	2015-12-08	compostos orgânicos
BRPI0915018A2 (pt)	2015-10-27	compostos orgânicos
BRPI0718874A2 (pt)	2015-06-23	Compostos orgânicos
NO20084803L (no)	2008-11-19	organiske forbindelser
BRPI0718478A2 (pt)	2013-11-26	Compostos orgânicos
DK2310359T3 (da)	2014-04-07	Organiske forbindelser
BRPI0917574A2 (pt)	2015-11-17	compostos orgânicos
BRPI0921826A2 (pt)	2016-01-12	compostos orgânicos
BRPI0907611A2 (pt)	2015-07-21	Compostos orgânicos
BRPI0821401A2 (pt)	2014-10-14	Compostos orgânicos
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
DK2185567T3 (da)	2011-05-16	Substituerede bicyclolactam-forbindelser
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
BRPI0712902A2 (pt)	2018-10-30	compostos orgânicos

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
2019-02-12	B07E	Notice of approval relating to section 229 industrial property law	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-04-02	B07A	Technical examination (opinion): publication of technical examination (opinion)
2019-07-16	B09B	Decision: refusal
2019-10-01	B09B	Decision: refusal	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL